Divi's Laboratories Limited (DIVISLAB) Price & Analysis

Compare

5 Followers

DIVISLAB Stock Chart & Stats

₹6603.05

-₹20.75(-0.35%)

At close: Jan 09 4:00 PM EST

₹6603.05

-₹20.75(-0.35%)

Day’s Range― - ―

52-Week Range₹4,941.70 - ₹7,077.70

Previous CloseN/A

Volume63.15K

Average Volume (3M)6.45K

Market Cap

₹1.71T

Enterprise Value₹1.48T

Total Cash (Recent Filing)₹35.27B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)68.7

Beta0.98

Next Earnings

Feb 05, 2026

EPS Estimate

23.51

Next Dividend Ex-DateN/A

Dividend Yield0.47%

Share Statistics

EPS (TTM)25.97

Shares Outstanding265,468,570

10 Day Avg. Volume2,471

30 Day Avg. Volume6,452

Financial Highlights & Ratios

PEG Ratio1.82

Price to Book (P/B)9.84

Price to Sales (P/S)15.74

P/FCF Ratio290.01

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹6,866.67

Price Target Upside3.99% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

EPS Forecast (FY)97.87

Revenue Forecast (FY)₹106.85B

Divi's Laboratories Limited News

Divi’s Laboratories Releases Unaudited Financial Results for September 2025

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) just unveiled an announcement. Divi’s Laboratories Limited announced the publication of its...

1M ago

Divi’s Laboratories Announces Trading Window Closure

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) just unveiled an announcement. Divi’s Laboratories Limited has announced the closure of...

3M ago

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has provided an announcement. Divi’s Laboratories Limited has released the transcript of...

4M ago

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an announcement. Divi’s Laboratories Limited has announced its unaudited financial...

4M ago

DIVISLAB FAQ

What was Divi's Laboratories Limited’s price range in the past 12 months?

Divi's Laboratories Limited lowest stock price was ₹4941.70 and its highest was ₹7077.70 in the past 12 months.

What is Divi's Laboratories Limited’s market cap?

Divi's Laboratories Limited’s market cap is ₹1.71T.

When is Divi's Laboratories Limited’s upcoming earnings report date?

Divi's Laboratories Limited’s upcoming earnings report date is Feb 05, 2026 which is in 51 days.

How were Divi's Laboratories Limited’s earnings last quarter?

Divi's Laboratories Limited released its earnings results on Nov 07, 2025. The company reported ₹25.97 earnings per share for the quarter, beating the consensus estimate of ₹22.901 by ₹3.069.

Is Divi's Laboratories Limited overvalued?

According to Wall Street analysts Divi's Laboratories Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Divi's Laboratories Limited pay dividends?

Divi's Laboratories Limited pays a Annually dividend of ₹30 which represents an annual dividend yield of 0.47%. See more information on Divi's Laboratories Limited dividends here

What is Divi's Laboratories Limited’s EPS estimate?

Divi's Laboratories Limited’s EPS estimate is 23.51.

How many shares outstanding does Divi's Laboratories Limited have?

Divi's Laboratories Limited has 265,468,570 shares outstanding.

What happened to Divi's Laboratories Limited’s price movement after its last earnings report?

Divi's Laboratories Limited reported an EPS of ₹25.97 in its last earnings report, beating expectations of ₹22.901. Following the earnings report the stock price went down -3.338%.

Which hedge fund is a major shareholder of Divi's Laboratories Limited?

Currently, no hedge funds are holding shares in IN:DIVISLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Divi's Laboratories Limited

Divi's Laboratories Limited (DIVISLAB) is a leading Indian pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. Established in 1990, the company operates primarily in the sectors of pharmaceuticals and biotechnology, focusing on high-value products such as anti-retroviral, cardiology, and other therapeutic segments. Divi's Laboratories is renowned for its world-class manufacturing facilities and commitment to quality, catering to both domestic and global markets.

Divi's Laboratories Limited (DIVISLAB) Earnings & Revenues

Historic Earnings Reports

DIVISLAB Stock 12 Month Forecast

Average Price Target

₹6,866.67

▲(3.99% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5398":"₹5,398","7801":"₹7,801","5998.75":"₹5,998.8","6599.5":"₹6,599.5","7200.25":"₹7,200.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7800,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6866.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹5.40K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5398,5998.75,6599.5,7200.25,7801],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5710.7,5871.415384615384,6032.130769230769,6192.846153846153,6353.5615384615385,6514.276923076923,6674.992307692308,6835.707692307692,6996.423076923077,7157.138461538461,7317.8538461538465,7478.569230769231,7639.284615384615,{"y":7800,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5710.7,5799.620769230769,5888.541538461538,5977.462307692307,6066.383076923077,6155.303846153846,6244.224615384615,6333.1453846153845,6422.066153846154,6510.986923076923,6599.907692307692,6688.828461538462,6777.749230769231,{"y":6866.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5710.7,5686.8,5662.9,5639,5615.099999999999,5591.2,5567.3,5543.4,5519.5,5495.6,5471.7,5447.8,5423.9,{"y":5400,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5399.22,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5867.19,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6221.87,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6221.87,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6043.44,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5550.63,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5452.68,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5523.35,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6058.57,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6819.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6359,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6091.05,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5710.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >